-
Pharmacology
-
- - Enzymes
-
- ATPase & GTPase
- Caspase
- Cholinesterase
- Coenzymes
- Cyclase
- Cyclooxygenase
- Cytochrome P450
- Deacetylase
- Dehydrogenase
- Demethylase
- Hydrolase
- Isomerase
- Kinase
- Oxidases
- Oxygenase
- Phosphatase
- Phosphodiesterase
- Phospholipase & Lipase
- Polymerase
- Protease
- Reductase
- Secretase
- Synthetase & synthase
- Telomerase
- Transaminase
- Transferase
- Ion Channels
- Receptors & Transporters
-
- Adenosine
- Adrenoceptors
- Cannabinoid
- Catalytic Receptors
- Chemokine
- Dopamine
- Enzyme-Linked Receptors
- G protein-coupled estrogen
- GABA
- Glutamate
- Glycine
- Histamine
- Imidazoline
- Inositol triphosphate receptor
- Melatonin
- Muscarinic
- Nicotinic
- Nuclear Receptors
- Opioids
- Peptide Receptors
-
- Angiotensin
- Apelin
- AXOR
- Bombesin
- Bradykinin
- CCK
- Endothelin
- Galanin
- Ghrelin
- Glucagon and Related Receptors
- LHRH
- Melanocortin
- Melanocyte Stimulating Hormone
- Motilin
- Neuromedin
- Neuropeptide FF/AF Receptors
- Neuropeptide S
- Neuropeptide Y
- Neurotensin
- Orexin
- Other
- Oxytocin
- PAR
- Secretin receptor
- Sensory Neuron Specific Receptor
- Somatostatin
- Substance P
- Tachykinins
- Vasopressin
- VIP
- Prostanoid
- Purinergics
- Serotonin
- Sigma
- Smoothened
- Sphingosine 1-Phosphate Receptors
- TGR5
- Toll-like Receptors
- Transporters
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Epigenetics
- Extracellular matrix & cell adhesion
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
-
Research Area
-
- Addiction
- Alzheimer's Disease
-
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Muscarinic
- Nicotinic
- Nitric oxide signaling
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Cancer
-
- Angiogenesis
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Epigenetics
- Extracellular matrix & cell adhesion
- Nuclear Receptors
- Signal transduction
- Depression
- Diabetes
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Heart disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Calcium
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Hypertension
-
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Obesity
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Serotonin
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Pain & inflammation
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- GABA
- Glutamate
- Histamine
- Immunomodulators
- Nitric oxide signaling
- Opioids
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Parkinson's Disease
- Respiratory disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Histamine
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Schizophrenia
- Stress / Anxiety
- Stroke
-
- Adenosine
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
We have 451 products in: Biochemicals >> Pharmacology >> Enzymes
Enzyme modulators beginning with A - B |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| AMP-activated protein kinase activator Purity: > 99% |   | ||
| Active metabolite of leflunomide. Dihydroorotate dehydrogenase inhibitor. Purity: > 98% |  | ||
| Phospholipase-A2 inhibitor Purity: > 98% | | ||
| Phytohormone; produced by a variety of cells in humans and animals Purity: > 99% | | ||
| Reversible granzyme B and caspase-8 inhibitor Purity: > 95% | | ||
| Potent α-glucosidase inhibitor Purity: > 98% | | ||
| Selective COX-3 inhibitor Purity: > 98% | | ||
| γ-glutamyl transpeptidase inhibitor Purity: > 98% | | ||
| Topoisomerase I and II inhibitor Purity: > 95% | | ||
| Inhibits viral DNA polymerase. Antiherpetic agent Purity: > 99% | | ||
| Second messenger. PKA activator. Purity: > 98% | | ||
| Tyrosine kinase inhibitor Purity: > 98% | | ||
| Non-selective tyrosine kinase inhibitor Purity: > 98% | | ||
| Selective PDGFR tyrosine kinase inhibitor Purity: > 99% | | ||
| Potent specific PDGF receptor tyrosine kinase inhibitor Purity: > 99% | | ||
| JAK2/3 inhibitor Purity: > 99% | | ||
| Selective reversible cell-permeable sirtuin2 (SIRT2) inhibitor Purity: > 95% | | ||
| Cell-permeable activator of AMP-activated protein kinase Purity: > 98% |  | ||
| Potent isozyme selective Akt1/2 kinase inhibitor Purity: > 97% | | ||
| Calpain and cathepsin inhibitor Purity: > 95% | | ||
| Calpain inhibitor Purity: > 95% | | ||
| Potent, selective and reversible protein arginine methyltransferase inhibitor Purity: > 98% | | ||
| PARP inhibitor Purity: > 99% | | ||
| NOS inhibitor Purity: > 98% | | ||
| Alkaline phosphatase substrate Purity: > 97% | | ||
| Protein synthesis inhibitor Purity: > 98% | | ||
| Potent HDAC inhibitor Purity: > 95% | | ||
| Selective NADPH-oxidase inhibitor Purity: > 99% | | ||
| Cytochrome c caspase activator and apoptosis inducer Purity: > 99% | | ||
| Highly selective GSK-3 inhibitor Purity: > 99% | | ||
| Fluorogenic substrate for fatty acid amide hydrolase (FAAH) Purity: > 99% | | ||
| Potent and selective PI3Kγ inhibitor Purity: > 98% | | ||
| Potent and selective PI3Kγ inhibitor Purity: > 95% | | ||
| Selective, ATP-competitive PI3Kγ inhibitor Purity: > 98% | | ||
| Potent and selective PI3Kγ inhibitor Purity: > 98% | | ||
| Calcineurin/PP2B inhibitor. Immunosuppressant and antifungal activity. Purity: > 98% | | ||
| Potent HMG-CoA reductase inhibitor Purity: > 99% | | ||
| Potent epoxide hydrolase inhibitor. Antihypertensive. Purity: > 98% | | ||
| Apoptosis inhibitor | | ||
| Novel, potent and selective JAK2 inhibitor Purity: > 95% | | ||
| Potent DNA methyltransferase inhibitor; epigenetic modifier Purity: > 99% | | ||
| Potent SIRT2 inhibitor Purity: > 95% | | ||
| Highly potent, selective (V)-ATPase inhibitor Purity: > 98% | | ||
| Flavonoid. Lipoxygenase inhibitor. Purity: > 98% | | ||
| Potent, broad-spectrum MMP inhibitor Purity: > 98% | | ||
| Potent, selective, cell-permeable Syk kinase inhibitor Purity: > 98% | | ||
| Angiotensin-converting enzyme (ACE) inhibitor. Prodrug. Purity: > 99% | | ||
| Aminopeptidase inhibitor; immunomodulator Purity: > 99% | | ||
| Cell-permeable, ATP-competitive 7 Arabidopsis GSK-3 inhibitor Purity: > 95% | | ||
| Biotin-conjugated, potent, irreversible caspase-3 inhibitor. Cell-permeable. Purity: > 95% | | ||
| Biotinylated, irreversible caspase-8 inhibitor Purity: > 95% | | ||
| Pan-caspase inhibitor Purity: > 95% | | ||
| Apoptotic anti-cancer, anti-inflammatory and anti-oxidant curcuminoid Purity: > 98% | | ||
| Potent G9a and G9a-like protein histone lysine methyltransferase inhibitor Purity: > 95% | | ||
| HDAC inhibitor Purity: > 98% | | ||
| Potent cathepsin K inhibitor Purity: > 98% | | ||
| Potent Cdk5/p25 and Cdk2 inhibitor Purity: > 98% | | ||
| Irreversible general caspase inhibitor. Cell-permeable. Purity: > 95% | | ||
| Substrate based inhibitor of γ-secretase (γ-40 site) Purity: > 98% | | ||
| Telomerase inhibitor Purity: > 97% | | ||
| Potent protein phosphotyrosine phosphatase inhibitor. PTEN inhibitor. Purity: > 98% | | ||
| Selective PDE7 inhibitor Purity: > 98% | | ||
| Non-selective myosin ATPase inhibitor | | ||
| Cell permeable, selective, ATP-competitive cyclin-dependent kinase (CDK) inhibitor Purity: > 99% | | ||
| Histone acetyltransferase Gcn5 inhibitor Purity: > 99% | | ||
| Non-competitive, irreversible protein tyrosine phosphatase (PTP) inhibitor Purity: > 99% | |